NCT04452760

Brief Summary

Multiple Sclerosis (ME) is a degenerative, inflammatory and autoimmune demyelinating disease of the central nervous system, characterized by demyelination due to inflammation and degeneration of the myelin sheaths enveloping nerves of the eye, periventricular grey matter, brain, spinal cord and brainstem. The symptoms associated with MS include symptomatic fatigue, muscle weakness, ataxia, mobility and balance problems or cognitive problems. Strength training has been shown to improve strength and mobility in persons with MS.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
36

participants targeted

Target at P25-P50 for not_applicable multiple-sclerosis

Timeline
Completed

Started Jul 2020

Shorter than P25 for not_applicable multiple-sclerosis

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 24, 2020

Completed
6 days until next milestone

First Posted

Study publicly available on registry

June 30, 2020

Completed
15 days until next milestone

Study Start

First participant enrolled

July 15, 2020

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2020

Completed
4 days until next milestone

Study Completion

Last participant's last visit for all outcomes

October 5, 2020

Completed
Last Updated

October 8, 2020

Status Verified

October 1, 2020

Enrollment Period

3 months

First QC Date

June 24, 2020

Last Update Submit

October 7, 2020

Conditions

Keywords

neurological disordersresistance trainingstrength trainingsleep qualityneuromuscular performancefunctional capacity

Outcome Measures

Primary Outcomes (8)

  • Maximal Voluntary Isometric Contraction of Knee Extension

    the maximum force (N) that can be produced voluntarily by the knee extension muscles during an isometric contraction is measured. The leg of the participant is fixed to an isokinetic device, and the participant makes a 5-second attempt, developing all the strength he or she can.

    Before the program training

  • Maximal Voluntary Isometric Contraction of Knee Extension

    the maximum force (N) that can be produced voluntarily by the knee extension muscles during an isometric contraction is measured. The leg of the participant is fixed to an isokinetic device, and the participant makes a 5-second attempt, developing all the strength he or she can.

    After 10 weeks

  • Rate of Force Development

    Rate of force development in knee extension

    Before the program training

  • Rate of Force Development

    Rate of force development in knee extension

    After 10 weeks

  • Central Activation Ratio

    The central activation ratio (CAR) was determined using superimposed electrical stimulation during maximum voluntary contractions

    Before the program training

  • Central Activation Ratio

    The central activation ratio (CAR) was determined using superimposed electrical stimulation during maximum voluntary contractions

    After 10 weeks

  • Spasticity

    Pendulum test

    Before the program training

  • Spasticity

    Pendulum test

    After 10 weeks

Secondary Outcomes (10)

  • Walking speed

    Before the program training

  • Walking speed

    After 10 weeks

  • Static Balance

    Before the program training

  • Static Balance

    After 10 weeks

  • Functional capacity

    Before the program training

  • +5 more secondary outcomes

Study Arms (2)

Control group

ACTIVE COMPARATOR

Only testing sessions

Other: Testing sessions

Progressive resistance training group

EXPERIMENTAL

10-weeks of progressive resistance training group. Leg press, leg extension, calf raises, hip extension exercises.

Other: Physical exerciseOther: Testing sessions

Interventions

Physical exercise intervention

Progressive resistance training group

Testing sessions

Control groupProgressive resistance training group

Eligibility Criteria

Age20 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • mild or moderate disability with clinical mild spastic-ataxic gait disorder.
  • stable phase of the disease.

You may not qualify if:

  • Expanded Disability Status Scale (EDSS) \< 6.
  • relapsing disease within the preceding 12 months.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Universidad Católica San Antonio

Murcia, 30107, Spain

Location

Related Publications (2)

  • Andreu-Caravaca L, Ramos-Campo DJ, Chung LH, Rubio-Arias JA. Can strength training modify voluntary activation, contractile properties and spasticity in Multiple Sclerosis?: A randomized controlled trial. Physiol Behav. 2022 Oct 15;255:113932. doi: 10.1016/j.physbeh.2022.113932. Epub 2022 Jul 27.

  • Andreu-Caravaca L, Ramos-Campo DJ, Abellan-Aynes O, Avila-Gandia V, Chung LH, Manonelles P, Rubio-Arias JA. 10-Weeks of resistance training improves sleep quality and cardiac autonomic control in persons with multiple sclerosis. Disabil Rehabil. 2022 Sep;44(18):5241-5249. doi: 10.1080/09638288.2021.1934738. Epub 2021 Jun 9.

MeSH Terms

Conditions

Multiple SclerosisNervous System DiseasesSleep Initiation and Maintenance Disorders

Interventions

Exercise

Condition Hierarchy (Ancestors)

Demyelinating Autoimmune Diseases, CNSAutoimmune Diseases of the Nervous SystemDemyelinating DiseasesAutoimmune DiseasesImmune System DiseasesSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Jacobo Á Rubio-Arias, Dr

    Universidad Politecnica de Madrid

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

June 24, 2020

First Posted

June 30, 2020

Study Start

July 15, 2020

Primary Completion

October 1, 2020

Study Completion

October 5, 2020

Last Updated

October 8, 2020

Record last verified: 2020-10

Data Sharing

IPD Sharing
Will share

The data will be published in a journal

Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
After the completion of study
Access Criteria
The data will be published in a journal

Locations